InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AYX | Ann: Removal from Official List at close 21/06/20 | 20/06/12 | 0 | 330 | |||
|
|||||||
AYX | Ann: Delisting from ASX | 20/06/12 | 0 | 318 | |||
|
|||||||
AYX | Ann: Results of Meeting | 14/06/12 | 0 | 276 | |||
|
|||||||
AYX | Ann: Chairman's Address to Shareholders | 14/06/12 | 0 | 300 | |||
|
|||||||
AYX | Ann: Issue of Securities | 25/05/12 | 0 | 292 | |||
|
|||||||
AYX | Ann: Notice of Extraordinary General Meeting/Prox | 11/05/12 | 0 | 182 | |||
|
|||||||
AYX | Ann: Shareholder Update | 08/05/12 | 0 | 238 | |||
|
|||||||
AYX | Ann: Austofix to seek Shareholder Approval to Del | 30/04/12 | 0 | 263 | |||
|
See All Discussions